{"id":6171,"date":"2014-04-15T16:44:16","date_gmt":"2014-04-15T15:44:16","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=6171"},"modified":"2014-04-15T16:44:16","modified_gmt":"2014-04-15T15:44:16","slug":"insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/","title":{"rendered":"La eliminaci\u00f3n del sarampi\u00f3n, farmacoterapia y m\u00e1s al nuevo n\u00famero de Circular Farmac\u00e9utica (1er trimestre 2014)"},"content":{"rendered":"<p><strong><a href=\"https:\/\/www.cofb.org\/es\/c\/document_library\/get_file\/?uuid=f73bca3d-a5c5-4ccb-8ef0-a53002defc83&amp;groupId=10136\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignright  wp-image-6182\" alt=\"Sin t\u00edtulo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/04\/Sin-t\u00edtulo1.jpg\" width=\"199\" height=\"263\" \/><\/a><\/strong>Ya puede leer el\u00a0<span style=\"text-decoration: underline;\"><strong><a href=\"https:\/\/www.cofb.org\/es\/c\/document_library\/get_file\/?uuid=f73bca3d-a5c5-4ccb-8ef0-a53002defc83&amp;groupId=10136\" target=\"_blank\" rel=\"noopener\">nuevo n\u00famero de la revista cient\u00edfica del\u00a0<\/a><\/strong><a href=\"https:\/\/www.cofb.org\/es\/c\/document_library\/get_file\/?uuid=f73bca3d-a5c5-4ccb-8ef0-a53002defc83&amp;groupId=10136\" target=\"_blank\" rel=\"noopener\"><strong>Col\u00b7legi <em>Circular\u00a0<\/em><\/strong><\/a><strong><em><a href=\"https:\/\/www.cofb.org\/es\/c\/document_library\/get_file\/?uuid=f73bca3d-a5c5-4ccb-8ef0-a53002defc83&amp;groupId=10136\" target=\"_blank\" rel=\"noopener\">Farmac\u00e9utica<\/a><\/em><\/strong><\/span>, correspondiente al primer trimestre de 2014. Esta vez destaca, entre otros, un art\u00edculo del \u00e1mbito de la Salud P\u00fablica sobre el sarampi\u00f3n, el objetivo de la OMS de eliminarlo en Europa en 2015 y la situaci\u00f3n en Catalu\u00f1a en relaci\u00f3n a la enfermedad.<\/p>\n<p>Como es habitual, se incluyen art\u00edculos sobre farmacoterapia, casos cl\u00ednicos y otros contenidos relacionados con los distintos \u00e1mbitos de la farmacia. Dentro del apartado &quot;Docencia&quot;, un art\u00edculo trata del informe Almagro, elaborado por un grupo de farmac\u00e9uticos hace 30 a\u00f1os sobre la situaci\u00f3n de la profesi\u00f3n. \u00bfQu\u00e9 problemas detectaron? \u00bfQu\u00e9 caminos de futuro marcaron entonces? Lo podr\u00e1 leer en la Circular.<\/p>\n<p>Le detallamos los contenidos de este n\u00famero de la revista a continuaci\u00f3n:<\/p>\n<ul>\n<li><strong>Editorial:<\/strong> T. Casas\u00edn<\/li>\n<li><strong>Farmacoterapia<\/strong>: Tratamiento farmacol\u00f3gico de la hiperplasia benigna de pr\u00f3stata<\/li>\n<li><strong>Farmasistencia:<\/strong> Insuficiencia renal asociada a VIH \/ Gaxilosa en el diagn\u00f3stico de hipolactasia<\/li>\n<li><strong>Espigolante<\/strong><\/li>\n<li><strong>Casos Cl\u00ednicos: <\/strong>S\u00edndrome de Takotsubo asociado a tirotoxicosis<\/li>\n<li><strong>Docencia:<\/strong> El informe Almagro 30 a\u00f1os despu\u00e9s<\/li>\n<li><strong>Alimentaci\u00f3n y Nutrici\u00f3n:<\/strong> Pasado, presente y futuro de los complementos alimenticios<\/li>\n<li><strong>Salud P\u00fablica:<\/strong> La eliminaci\u00f3n del sarampi\u00f3n en Catalu\u00f1a<\/li>\n<li><strong>Innovadores<\/strong><\/li>\n<li><strong>Vademecum Cultural<\/strong><\/li>\n<\/ul>\n<p>Ver\u00a0<a href=\"http:\/\/www.cofb.org\/es\/web\/guest\/circular-farmaceutica\/\" target=\"_blank\" rel=\"noopener\">n\u00fameros anteriores de<em>\u00a0Circular Farmac\u00e9utica<\/em><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Ya puede leer el nuevo n\u00famero de la revista cient\u00edfica del Colegio Circular Farmac\u00e9utica, correspondiente al primer trimestre de 2014. Esta vez destaca, entre otros, un art\u00edculo del \u00e1mbito de la Salud P\u00fablica sobre el sarampi\u00f3n, el objetivo de la OMS de eliminarlo en Europa en 2015 y la situaci\u00f3n en Catalu\u00f1a en relaci\u00f3n a la [\u2026]<\/p>","protected":false},"author":1,"featured_media":6182,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[32],"tags":[2149],"class_list":["post-6171","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-farmacia","tag-publicacions"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L&#039;eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014) - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014) - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Ja podeu llegir el\u00a0nou n\u00famero de la revista cient\u00edfica del\u00a0Col\u00b7legi Circular\u00a0Farmac\u00e8utica, corresponent al primer trimestre de 2014. Aquest cop destaca, entre d&#8217;altres, un article de l&#8217;\u00e0mbit de la Salut P\u00fablica sobre el xarampi\u00f3, l&#8217;objectiu de l&#8217;OMS d&#8217;eliminar-lo a Europa l&#8217;any 2015 i la situaci\u00f3 a Catalunya en relaci\u00f3 a la [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-15T15:44:16+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"L&#8217;eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014)\",\"datePublished\":\"2014-04-15T15:44:16+00:00\",\"dateModified\":\"2014-04-15T15:44:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/\"},\"wordCount\":246,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Publicacions\"],\"articleSection\":[\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/\",\"name\":\"L'eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014) - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-04-15T15:44:16+00:00\",\"dateModified\":\"2014-04-15T15:44:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L&#8217;eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014) - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/","og_locale":"es_ES","og_type":"article","og_title":"L'eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014) - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Ja podeu llegir el\u00a0nou n\u00famero de la revista cient\u00edfica del\u00a0Col\u00b7legi Circular\u00a0Farmac\u00e8utica, corresponent al primer trimestre de 2014. Aquest cop destaca, entre d&#8217;altres, un article de l&#8217;\u00e0mbit de la Salut P\u00fablica sobre el xarampi\u00f3, l&#8217;objectiu de l&#8217;OMS d&#8217;eliminar-lo a Europa l&#8217;any 2015 i la situaci\u00f3 a Catalunya en relaci\u00f3 a la [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-04-15T15:44:16+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"L&#8217;eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014)","datePublished":"2014-04-15T15:44:16+00:00","dateModified":"2014-04-15T15:44:16+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/"},"wordCount":246,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"","keywords":["Publicacions"],"articleSection":["Not\u00edcies farm\u00e0cia"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/","url":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/","name":"L'eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014) - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-04-15T15:44:16+00:00","dateModified":"2014-04-15T15:44:16+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/04\/15\/insuficiencia-renal-associada-a-vih-un-dels-temes-del-nou-numero-de-circular-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"L&#8217;eliminaci\u00f3 del xarampi\u00f3, farmacoter\u00e0pia i m\u00e9s al nou n\u00famero de Circular Farmac\u00e8utica (1er trimestre 2014)"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Ja podeu llegir el\u00a0nou n\u00famero de la revista cient\u00edfica del\u00a0Col\u00b7legi Circular\u00a0Farmac\u00e8utica, corresponent al primer trimestre de 2014. Aquest cop destaca, entre d&#8217;altres, un article de l&#8217;\u00e0mbit de la Salut P\u00fablica sobre el xarampi\u00f3, l&#8217;objectiu de l&#8217;OMS d&#8217;eliminar-lo a Europa l&#8217;any 2015 i la situaci\u00f3 a Catalunya en relaci\u00f3 a la [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/6171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=6171"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/6171\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=6171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=6171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=6171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}